$ANAB 4 SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: Renton Hollings, Director Received 5,000 shares by exercise or conversion ($90.2K) · Sold 5,000 shares ($249K)
17 Sep 2026	Form 4: Orwin John A, Director Received 1,300 shares by exercise or conversion
07 Aug 2026	Form 4: Lizzul Paul F., Chief Medical Officer Granted 16,667 Performance Stock Units
07 Aug 2026	Form 4: Faga Daniel, Director Granted 53,334 Performance Stock Units
17 Jun 2026	Form 4: Renton Hollings, Director Received 6,030 shares by exercise or conversion
17 Jun 2026	Form 4: Schmid John P., Director Received 6,030 shares by exercise or conversion
17 Jun 2026	Form 4: Orwin John A, Director Received 6,030 shares by exercise or conversion
13 May 2026	Form 4: Hughes Owen, Director Granted 11,250 Restricted Stock Units
13 May 2026	Form 4: Murphy Christopher M., Chief Financial Officer Granted 25,765 Restricted Stock Units
29 Apr 2026	Form 4: Gray Susannah, Director Granted 11,250 Restricted Stock Unit
22 Apr 2026	Form 4: Orwin John A, Director Disposed of 55,181 Stock Option (right to buy) (Disposition to Issuer) · Granted 55,181 Stock Option (right to buy)
22 Apr 2026	Form 4: Schmid John P., Director Disposed of 107,320 Stock Option (right to buy) (Disposition to Issuer) · Granted 107,320 Stock Option (right to buy)
22 Apr 2026	Form 4: Renton Hollings, Director Disposed of 107,320 Stock Option (right to buy) (Disposition to Issuer) · Granted 107,320 Stock Option (right to buy)
22 Apr 2026	Form 4: Faga Daniel, Director Disposed of 1,035,941 Employee Stock Option (right to buy) (Disposition to Issuer) · Granted 1,035,941 Employee Stock Option (right to buy)
22 Apr 2026	Form 4: ANAPTYSBIO, Inc, 10% owner · First Tracks Biotherapeutics Inc Disposed of 100 shares (Other Transaction)
01 Apr 2026	Form 4: Schmid John P., Director Sold 20,645 shares ($1.16M)
27 Mar 2026	Form 4: Faga Daniel, Director Received 34,300 shares as a grant or award · Sold 17,679 shares ($1.09M)
13 Feb 2026	Form 4: Loumeau Eric J, CHIEF LEGAL OFFICER Received 10,000 shares by exercise or conversion ($297K) · Sold 10,000 shares ($540K)
16 Jan 2026	Form 4: Marquet Magda, Director Received 11,000 shares by exercise or conversion ($287K) · Sold 11,000 shares ($531K)
09 Jan 2026	Form 4: Mulroy Dennis, CHIEF FINANCIAL OFFICER Received 6,700 shares by exercise or conversion · Sold 2,515 shares ($112K)

Comments